Girl with Cystic Fibrosis helps raise $85k for hospital
Sutton, 1, who lives with her parents Brittany and Jeff in greater Decatur, faces a lifetime of dangers, from dangerous lung infections, to obstructions of the pancreas. She currently receives treatment at Children's Healthcare of Atlanta. On Dec. 11 ... - Wed, 17 Dec 2014 13:00

My Mother, My Disease, and Me
My mother has learned about Ayurveda, an ancient healthcare system from India, and has driven me through several hours of January snow to a spa in Huntsville, Ontario, where she hopes the words cystic fibrosis will be abolished from our vocabulary.
The Atlantic - Thu, 11 Dec 2014 05:45

Metabolism Influences Fibrosis in SSc
Metabolism Fibrosis and metabolism: the two were recently linked in a study presented at the 2014 American College of Rheumatology Meeting in November. “Adiponectin Is an Endogenous Anti-Fibrotic and Target in Systemic Sclerosis: Novel Link Between ...
Scleroderma News - Mon, 15 Dec 2014 10:53

iBio Announces Updates on Anti-fibrosis Plant-grown Protein CFB03 For IPF, SSc
iBio On Dec 10, 2014 iBio, Inc. revealed progress in developing IBIO-CFB03, a treatment for idiopathic pulmonary fibrosis (IPF), systemic sclerosis (SSc), and other fibrotic diseases at its Annual Meeting. Unlike other proteins, which are produced by ...
Pulmonary Hypertension News - Mon, 15 Dec 2014 04:50

Study Reveals Association Between Pulmonary Fibrosis and Rheumatoid ...
Diffuse parenchymal lung disease (DPLD) is a heterogeneous group of disorders characterized by inflammation and/or fibrosis of the parenchymal interstitium of the lung. Progression of disease results in impaired oxygen transfer and scarring within the ...
Pulmonary Fibrosis News - Thu, 18 Dec 2014 13:33

Cystic fibrosis group invests $15M in treatment research
Cystic Fibrosis Foundation Therapeutics, the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation of Bethesda, signed a $15 million agreement with Shire to help develop a new treatment targeting the underlying cause of ...
Gazette.Net: Maryland Community News Online - Wed, 17 Dec 2014 04:33

Second Component of Promising Investigational Cystic Fibrosis Combo ...
shutterstock_214333159 Galapagos is a company specializing in novel mechanisms of small-molecule and antibody programs for cystic fibrosis. In a recent press release, the company revealed that before the end of 2015, they are going to conduct a Phase 1 ...
Cystic Fibrosis News Today - Fri, 12 Dec 2014 09:52

Galapagos selects second component of its investigational cystic fibrosis ... (press release) - Thu, 11 Dec 2014 22:22

The hunt for botanicals
The only anti-fibrotic drug currently registered in Europe and the US, pirfenidone, has shown some beneficial effects in patients with idiopathic pulmonary fibrosis and fibrotic kidney diseases, but its clinical efficacy on fibrosis remains equivocal ...
Medical Xpress - Fri, 19 Dec 2014 05:52

<-   1  2  3  4  5  6  7  8    ->

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014